MedTrace Logo

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

NCT07005362 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2026-05-19

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages.

The main question it aims to answer is:

Does providing a wearable fitness and activity tracker plus AI-tailored and DSMES improve clinical outcomes for patients with type 2 diabetes?

Participants will complete a baseline visit, wear a Fitbit and answer text messages for 12-weeks, and complete by a final visit.

Conditions

  • Type 2 Diabetes
  • Type 2 Diabetes Mellitus (T2DM)
  • T2DM (Type 2 Diabetes Mellitus)
  • T2D
  • T2DM
  • Remote Patient Monitoring
  • Artificial Intelegence

Interventions

BEHAVIORAL

Fitbit and AI Chatbot

Participants will wear their Fitbit devices daily for 12-weeks and will receive personalized messages from the AI Chatbot every week with a new exercise recommendation based on their previous week's activity level. Additionally, they can engage with the AI Chatbot through text message for further support and education.

OTHER

Routine Care

The control group will consist of patients with type 2 diabetes who meet the study's inclusion criteria but have not participated in the intervention.

Sponsors & Collaborators

  • American Academy of Family Physicians

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Seth Kramer, DO, MPH · University of Colorado Anschutz Medical School

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-03
Primary Completion
2026-08-30
Completion
2026-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07005362 on ClinicalTrials.gov